what receptors does tirzepatide work on The GLP-1R-GIPR co-agonist tirzepatide soon reaches patients with type 2 diabetes – Switching from tirzepatide to retatrutide:

Tirzepatide is a peptide that targets GLP-1 and GIP receptors

Tirzepatide (Mounjaro/Zepbound) is a GIP/GLP-1 dual agonist FDA-approved and widely available

More providers like Hims & Hers and Sesame are expected to come online soon

The pathophysiology of T2D is progressive and involves multiple defects that contribute to chronic hyperglycaemia

Critical structural elements of GLP-1 sequence Early structure-activity studies of endogenous GLP-1 revealed the key sequence domains that correlate with potency and enzymatic degradation

Seniors should aim to drink at least 8 glasses of water per day or more if they engage in intense physical activity